SARC's Podcast SARCTalk Continues to Inform and Inspire the Sarcoma Community
SARCTalk brings together leading oncologists, researchers, patient advocates, and survivors to discuss key topics ranging from groundbreaking clinical trials and emerging therapies to the personal journeys of those affected by sarcoma. 'SARCTalk plays a vital role in bridging the gap between scientific research and patient outcomes by fostering open dialogue and sharing sarcoma experts' knowledge with both lay and professional audiences,' said Scott Okuno MD, originator and host of SARCTalk and Chief Medical Officer of SARC. Dr. Okuno is a medical oncologist at Mayo Clinic.
Each season of SARCTalk has expanded its impact, covering diverse topics such as:
Cutting-edge research and clinical trials
Patient and survivor stories of resilience
Advances in precision medicine and immunotherapy
The role of advocacy in driving change
Expert guidance on treatment options and supportive care
Mentorship and career development
'We created SARCTalk to bring the latest advancements in sarcoma research directly to those who need it most,' said Steven Young, President and CEO at SARC. 'The response has been incredible, and it's clear that this platform is helping to educate, empower, and connect the sarcoma community like never before.'
Listeners can tune in to SARCTalk (for audio only) on Spotify & Apple Podcast and (plus video) YouTube & SARC's website https://sarctrials.org/resources/sarc-podcast. Stay connected with SARC for the latest sarcoma research and advocacy updates at https://sarctrials.org/.
About SARC
SARC (Sarcoma Alliance for Research Through Collaboration) is a US-based, non-profit public charity sarcoma research consortium solely dedicated to fostering progress in the prevention and treatment of sarcoma to improve patient outcomes and ultimately find a cure.
SARC was formed in 2003 by the sarcoma research community to bring together the best cancer centers in the world supported by centralized infrastructure for the conduct of multi-institutional collaborative sarcoma research.
SARC has successfully established itself as a leader in providing a unified platform for sarcoma experts to collaborate and fast-track more dozens of Phase I-III clinical trials (with SARC as regulatory sponsor) across close to 100 medical centers with specialized sarcoma programs in the United States and globally.
What Is Sarcoma?
Sarcomas are cancers of the bony skeleton (the skull, vertebrae, ribs, and extremities), and the so-called soft tissues, including muscle and fat. Sarcomas are disproportionately common in children and young adults but occur at all ages. There are many different types of sarcomas, leading to diagnostic and therapeutic challenges. SARC and our collaborators are working to advance the science and treatment of sarcomas.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
7 hours ago
- The Star
New potential weight-loss drug targets found by researchers
There could be new hope for people aiming to fight obesity, following a research breakthrough identifying certain microproteins that store fat. In findings published in the Proceedings of the National Academy of Sciences (PNAS) in the United States, the team from the California-based Salk Institute for Biological Studies said that the microproteins 'could potentially serve as drug targets to treat obesity and other metabolic disorders'. The findings could prove particularly useful for people who struggle with other treatments, such as lifestyle changes, bariatric surgery or courses of drugs such as semaglutide. 'The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide,' the Salk Institute warned, reminding that being overweight is linked to 'other metabolic disorders' such as diabetes, cardiovascular (heart) diseases, chronic kidney disease and cancers. Microproteins, according to the team, are 'an understudied class of molecules found throughout the body that play roles in both health and disease'. The team believes the findings are noteworthy because they entailed the use of CRISPR gene editing to screen thousands of fat cell genes to try to find genes 'that likely code for microproteins that regulate either fat cell proliferation or lipid accumulation'. CRISPR screens work by cutting out genes of interest in cells and observing whether the cell thrives or dies without them. From these results, scientists can determine the importance and function of specific genes. 'We wanted to know if there was anything we had been missing in all these years of research into the body's metabolic processes,' says study first author and postdoctoral researcher Dr Victor Pai. 'And CRISPR allows us to pick out interesting and functional genes that specifically impact lipid accumulation and fat cell development.' He adds that: 'We're not the first to screen for microproteins with CRISPR, but we're the first to look for microproteins involved in fat cell proliferation. "This is a huge step for metabolism and obesity research.'– dpa
Malaysian Reserve
10 hours ago
- Malaysian Reserve
Geri Care opens its 10th facility at Velachery: state-of-the-art Assisted Living for Elders with India's First Dialysis Day Care Centre
CHENNAI, India, Aug. 20, 2025 /PRNewswire/ — Geri Care, India's pioneer in integrated eldercare, today announced the inauguration of its newest Assisted Living facility in Velachery, Chennai. This milestone marks Geri Care's 10th facility since inception in 2018, a testament to the organisation's rapid growth and unwavering dedication to transforming eldercare in India. This newest 75-bed, state-of-the-art Assisted Living facility is designed for elders requiring expert medical care, including post-surgery recovery, chronic condition management, dementia care, and post-hospitalisation support. As part of this centre, Geri Care is introducing India's first Dialysis Day-care Centre for Elders that will spare families the strain of late-night treatments. Located in close proximity to the Geri Care Hospital, the facility also features a dedicated Elder Fitness Studio for physiotherapy and rehabilitation, along with beautifully landscaped Elder Grove spaces that encourage connection, relaxation, and rejuvenation for residents. The facility was inaugurated by National Award-winning actor, acclaimed filmmaker, and philanthropist, Ms. Suhasini Maniratnam, whose unwavering commitment to social causes extends to championing dignified eldercare, and Padma Shri Prof. Dr. V.S. Natarajan, widely regarded as the 'Father of Geriatric Medicine in India' and a pioneer in shaping the country's approach to senior healthcare. Speaking on the occasion, Dr. Lakshmipathy Ramesh, Founder & Managing Director of Geri Care Health Services said, 'This is a proud milestone for Geri Care. The launch of our state-of-the-art Assisted Living facility is where our vision meets the growing healthcare needs of India's elders. With over 10% of our population aged 60 and above, projected to nearly double by 2050; the demand for specialised eldercare has never been greater.' He added, 'Our 10th facility at Velachery is designed to set new benchmarks. Our dialysis day-care centre, geriatric clinic, elder fitness studio, and physiotherapy services are all open to elders in the neighbourhood. Every detail serves one purpose -to make life healthier, easier, and more dignified. At Geri Care, our mission goes beyond healthcare; it's about giving elders a place where they feel cared for, respected, and valued every day.' Inaugurating the facility, the Chief Guest, Ms. Suhasini Maniratnam said, 'Eldercare is a cause close to my heart, and Geri Care's work shows what true compassion in healthcare looks like. This facility is not just about medical support; it's about dignity, comfort, and giving our elders the quality of life they deserve.' Guest of Honour, Padma Shri Prof. Dr. V.S. Natarajan in his inaugural remarks said, 'Specialised geriatric care is the need of the hour in our ageing nation. Geri Care's 360 degree approach is a model for the future, blending medical excellence with genuine respect for the elderly.' About Geri Care: Founded in 2018 by renowned geriatricians Dr. Lakshmipathy Ramesh & Dr. V. Srinivas, Geri Care is India's first integrated healthcare network exclusively serving senior citizens. Its comprehensive ecosystem spans personalized Home Care, Hospital Services, Assisted Living Centres, and Specialty Geriatric Clinics. Geri Care operates India's first multi-specialty hospitals dedicated to seniors and currently serves over 50,000 elders across multiple cities. To learn more, visit Photo:
The Star
12 hours ago
- The Star
New policy in China fuels rise in fertility treatments
BEIJING: Unable to conceive naturally, Wang, a resident of Changchun in Northeast China's Jilin province, could not opt for fertility treatment due to the hefty cost — sometimes more than 20,000 yuan (US$2,785) per cycle. So when she learned that assisted reproductive services had been included in the province's medical insurance programme, she hesitated no more. Wang was reimbursed 10,263 yuan for her treatment session through medical insurance, which was nearly 70 per cent of the cost incurred. Since Jilin province introduced the reimbursement policy in July 2024, nearly 5,800 women have benefited, saving over 23 million yuan in total, according to the provincial healthcare security bureau. Beijing became the first region in the country to include reproductive technologies in its healthcare insurance programme in July 2023. Now, all 31 provincial-level regions offer similar facilities. 'Last year alone, these reimbursement policies benefited over 1 million people, helping them achieve their fertility goals,' said Ms Liu Juan, deputy director of the National Healthcare Security Administration's benefits and reimbursement department. Reimbursement ratios and coverage vary by region. For example, Beijing now covers 16 types of fertility treatments with a reimbursement rate of up to 70 per cent. In Jiangxi province, secondary hospitals offer 80 to 95 per cent coverage, while top-tier hospitals reimburse 60 to 80 per cent. 'Some provinces have also included labour pain relief in insurance programmes, easing both financial and physical burdens for pregnant women,' Liu said during a recent press conference. 'We have also accelerated the process of formulating pricing guidelines for services such as neonatal care and family-accompanied childbirth to help improve pediatric and obstetric services,' she said. China is keen to encourage births and build a fertility support system as the nation has gradually moved from a phase of population growth to a phase of decline, authorities said. He Dan, director of the China Population and Development Research Centre, cited data from the World Health Organisation, which said the optimal childbearing age range is 20 to 34 for women and 25 to 34 for men. Data shows that in 2020, Chinese people's average age for first marriage stood at 28.7 years, while the average age for first-time mothers was 29.7. About 1 million women of reproductive age lose fertility annually due to cancer treatments. The national infertility rate has also climbed from 12 per cent in 2007 to 18 percent in 2020, Ms He said in a signed article. She said that mainstream fertility preservation technologies include egg freezing, in vitro fertilisation, embryo cryopreservation for women and sperm freezing for men. 'It is crucial to advance reproductive health research and clinical applications while expanding insurance coverage for safe, reliable and affordable assisted reproductive services,' she added. In Jiangxi province, which began reimbursing fertility treatments in June 2024, public insurance covered at least 60 per cent of costs as of April, benefiting nearly 88,000 people. Jiangxi Maternal and Child Health Hospital reproductive health expert Tian Lifeng noted a marked increase in the number of infertile couples and women who get married at a relatively advanced age seeking consultations through online and offline channels. Since the policy's implementation, the number of monthly outpatient visits has increased by 15 to 20 per cent, the expert said. - China Daily/ANN
